| Supplementary Protection Certificate (SPC) Summary | |||
| SPC No. | 2019/010 | ||
|---|---|---|---|
| Date of filing | 20/02/2019 | ||
| Notification of Application Published | 20/03/2019 | ||
| Status | Rejected | ||
| Notification of Grant Published | |||
| Date of Expiry of SPC | |||
| Applicant |
ARRAY BIOPHARMA INC. 3200 Walnut Street Boulder Colorado 80301 UNITED STATES OF AMERICA |
||
| Patent Number | 2727918 | ||
| Title of Invention | Compounds and Compositions as Protein Kinase Inhibitors | ||
| Date of Expiry of Patent | 26/08/2030 | ||
| Product Type | Medicinal Product | ||
| Product Identity | Combination of binimetinib and encorafenib, each in all forms protected by the basic patent | Market Authorisation | Ireland | European Union |
| Authorisation No | EU/1/18/1315 | EU/1/18/1314 | |
| Authorisation Date | 24/09/2018 | 24/09/2018 | |
| Identity of Product Authorised | MEKTOVI(Binimetinib) | BRAFTOVI(encorafenib) | Market Authorisation | Ireland | European Union |
| Authorisation No | EU/1/18/1314 | EU/1/18/1315 | |
| Authorisation Date | 24/09/2018 | 24/09/2018 | |
| Identity of Product Authorised | BRAFTOVI(encorafenib) | MEKTOVI(Binimetinib) | |
| Address for Service |
HANNA MOORE + CURLEY Garryard House 25/26 Earlsfort Terrace Dublin 2 D02 PX51 IRELAND |
||
| Renewal Fees | |||
| 01/03/2019 | Request for grant a Supplementary Protection Certificate filed on 20/02/2019, numbered 2019/010. | ||
| 28/01/2021 | Request for grant of Supplementary Protection Certification No. 2019/010 rejected in respect of Article 10(2) of Regulation (EC) No. 469/2009 | ||
| 24/03/2021 | Written grounds of decision issued on 12 March 2021. | ||